Affordable Access

Regulation of adipocyte differentiation and insulin action with rapamycin.

Authors
  • Cho, Hye Jin
  • Park, Jiyoung
  • Lee, Hyun Woo
  • Lee, Yun Sok
  • Kim, Jae Bum
Type
Published Article
Journal
Biochemical and biophysical research communications
Publication Date
Sep 03, 2004
Volume
321
Issue
4
Pages
942–948
Identifiers
PMID: 15358118
Source
Medline
License
Unknown

Abstract

Here, we demonstrated that inhibition of mTOR with rapamycin has negative effects on adipocyte differentiation and insulin signaling. Rapamycin significantly reduced expression of most adipocyte marker genes including PPARgamma, adipsin, aP2, ADD1/SREBP1c, and FAS, and decreased intracellular lipid accumulation in 3T3-L1 and 3T3-F442A cells, suggesting that rapamycin would affect both lipogenesis and adipogenesis. Contrary to the previous report that suppressive effect of rapamycin on adipogenesis is limited to the clonal expansion, we revealed that its inhibitory effect persisted throughout the process of adipocyte differentiation. Thus, it is likely that constitutive activation of mTOR might be required for the execution of adipogenic programming. In differentiated 3T3-L1 adipocytes, chronic treatment of rapamycin blunted the phosphorylation of AKT and GSK, which is stimulated by insulin, and reduced insulin-dependent glucose uptake activity. Taken together, these results suggest that rapamycin not only prevents adipocyte differentiation by decrease of adipogenesis and lipogenesis but also downregulates insulin action in adipocytes, implying that mTOR would play important roles in adipogenesis and insulin action.

Report this publication

Statistics

Seen <100 times